169 related articles for article (PubMed ID: 24145403)
1. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.
Sandhu SK; Fassan M; Volinia S; Lovat F; Balatti V; Pekarsky Y; Croce CM
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18208-13. PubMed ID: 24145403
[TBL] [Abstract][Full Text] [Related]
2. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.
Sandhu SK; Volinia S; Costinean S; Galasso M; Neinast R; Santhanam R; Parthun MR; Perrotti D; Marcucci G; Garzon R; Croce CM
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20047-52. PubMed ID: 23169640
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.
Contreras JR; Palanichamy JK; Tran TM; Fernando TR; Rodriguez-Malave NI; Goswami N; Arboleda VA; Casero D; Rao DS
Oncotarget; 2015 May; 6(13):11023-37. PubMed ID: 25906746
[TBL] [Abstract][Full Text] [Related]
5. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.
Efanov A; Zanesi N; Nazaryan N; Santanam U; Palamarchuk A; Croce CM; Pekarsky Y
Leukemia; 2010 May; 24(5):970-5. PubMed ID: 20357824
[TBL] [Abstract][Full Text] [Related]
6. miR-15b/16-2 deletion promotes B-cell malignancies.
Lovat F; Fassan M; Gasparini P; Rizzotto L; Cascione L; Pizzi M; Vicentini C; Balatti V; Palmieri D; Costinean S; Croce CM
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11636-41. PubMed ID: 26324892
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.
Mu P; Han YC; Betel D; Yao E; Squatrito M; Ogrodowski P; de Stanchina E; D'Andrea A; Sander C; Ventura A
Genes Dev; 2009 Dec; 23(24):2806-11. PubMed ID: 20008931
[TBL] [Abstract][Full Text] [Related]
8. Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.
Enomoto Y; Kitaura J; Hatakeyama K; Watanuki J; Akasaka T; Kato N; Shimanuki M; Nishimura K; Takahashi M; Taniwaki M; Haferlach C; Siebert R; Dyer MJ; Asou N; Aburatani H; Nakakuma H; Kitamura T; Sonoki T
Leukemia; 2011 Dec; 25(12):1849-56. PubMed ID: 21738213
[TBL] [Abstract][Full Text] [Related]
9. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.
Costinean S; Sandhu SK; Pedersen IM; Tili E; Trotta R; Perrotti D; Ciarlariello D; Neviani P; Harb J; Kauffman LR; Shidham A; Croce CM
Blood; 2009 Aug; 114(7):1374-82. PubMed ID: 19520806
[TBL] [Abstract][Full Text] [Related]
10. miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.
Mihailovich M; Bremang M; Spadotto V; Musiani D; Vitale E; Varano G; Zambelli F; Mancuso FM; Cairns DA; Pavesi G; Casola S; Bonaldi T
Nat Commun; 2015 Nov; 6():8725. PubMed ID: 26555894
[TBL] [Abstract][Full Text] [Related]
11. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
12. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
13. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.
Gil VS; Bhagat G; Howell L; Zhang J; Kim CH; Stengel S; Vega F; Zelent A; Petrie K
Dis Model Mech; 2016 Dec; 9(12):1483-1495. PubMed ID: 27799148
[TBL] [Abstract][Full Text] [Related]
14. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
Li Y; Vecchiarelli-Federico LM; Li YJ; Egan SE; Spaner D; Hough MR; Ben-David Y
Blood; 2012 May; 119(19):4486-98. PubMed ID: 22451425
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
Musilova K; Mraz M
Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.
Inomata M; Tagawa H; Guo YM; Kameoka Y; Takahashi N; Sawada K
Blood; 2009 Jan; 113(2):396-402. PubMed ID: 18941111
[TBL] [Abstract][Full Text] [Related]
17. Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus.
Repellin CE; Tsimbouri PM; Philbey AW; Wilson JB
PLoS One; 2010 Feb; 5(2):e9092. PubMed ID: 20161707
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
[TBL] [Abstract][Full Text] [Related]
19. The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.
Battistella M; Romero M; Castro-Vega LJ; Gapihan G; Bouhidel F; Bagot M; Feugeas JP; Janin A
J Invest Dermatol; 2015 Jun; 135(6):1659-1667. PubMed ID: 25634356
[TBL] [Abstract][Full Text] [Related]
20. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
